Ke Cheng C - OmicsDI

Show results for

Unknown (489)
Proteomics (23)
Transcriptomics (9)
Metabolomics (3)
Genomics (2)

Organisms

Homo sapiens (20)
Mus musculus (8)
Salmonella enterica subsp. enterica serovar Paratyphi A (1)
Rattus norvegicus (1)
Solanum lycopersicum (1)
Oryza sativa (1)

Repository

pride (13)
biostudies-arrayexpress (10)
iProX (6)
MetaboLights (3)
MassIVE (2)
EGA (1)
PanoramaPublic (1)
PeptideAtlas (1)

Tissue

Cell culture (5)
Permanent cell line cell (2)
Brain (1)
Epithelial cell (1)
Hepatoma cell line (1)
Keratinocyte (1)
Kidney (1)
Malignant cell (1)
Skin (1)
Stem (1)

Disease

Disease free (2)
Colorectal carcinoma (1)
Coronavirus infectious disease (1)
FTDALS1 (1)
Liver cancer (1)
Lung cancer (1)
Prostate cancer (1)
Squamous cell carcinoma (1)

Technology Type

Mass Spectrometry (13)
Bottom-up proteomics (5)
Shotgun proteomics (4)
Mass spectrometry (3)
Affinity purification coupled with mass spectrometry proteomics (3)
Data-dependent acquisition (2)
DiaPASEF (1)

Instrument Platform

Orbitrap Exploris 480 (2)
Liquid Chromatography MS - Negative (LC-MS (Negative)) (1)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (1)
Liquid Chromatography MS - alternating - reverse phase (1)
Q Exactive (1)
LTQ Orbitrap (1)

Publication Date

2024 (6)
2011 (4)
2010 (3)
2025 (3)
2021 (3)
2026 (3)
2023 (2)
2020 (2)
2019 (2)
2022 (2)
2013 (2)
2016 (1)
2009 (1)
2004 (1)
2018 (1)

UNIPROT ID/AC

A0A024R8H9 (1)
A0A024RC46 (1)
A0A087WTX5 (1)
A0A087WVW2 (1)
A0A087WVZ5 (1)
A0A087WWA5 (1)
A0A087WWK8 (1)
A0A087WXI0 (1)
A0A087WYL9 (1)
A0A087X130 (1)
A0A087X1S3 (1)
A0A087X1V9 (1)
A0A0A0MR66 (1)
A0A0A0MS07 (1)
A0A0A0MS51 (1)
A0A0A0MSA7 (1)
A0A0C4DG89 (1)
A0A0C4DGT3 (1)
A0AVT1 (1)
A0FGR8 (1)
A0FGR8-2 (1)
A0FGR8-6 (1)
A0M8Q6 (1)
A0MZ66 (1)
A0PJX4 (1)
A1L0T0 (1)
A1L390 (1)
A2A3K4 (1)
A2BFH1 (1)
A2NUT2 (1)

ENSEMBL ID

ENSG00000170477 (1)
ENSG00000229353 (1)

CHEBI ID

CHEBI:10072 (1)
CHEBI:10362 (1)
CHEBI:131434 (1)
CHEBI:132188 (1)
CHEBI:132948 (1)
CHEBI:132966 (1)
CHEBI:132983 (1)
CHEBI:133005 (1)
CHEBI:133026 (1)
CHEBI:133028 (1)
CHEBI:133032 (1)
CHEBI:133046 (1)
CHEBI:133066 (1)
CHEBI:133089 (1)
CHEBI:133092 (1)
CHEBI:133096 (1)
CHEBI:133115 (1)
CHEBI:133119 (1)
CHEBI:133172 (1)
CHEBI:133176 (1)
CHEBI:133181 (1)
CHEBI:133185 (1)
CHEBI:133186 (1)
CHEBI:133197 (1)
CHEBI:133199 (1)
CHEBI:133223 (1)
CHEBI:133435 (1)
CHEBI:133459 (1)
CHEBI:133460 (1)
CHEBI:133469 (1)

Metabolite Name

(R)-3-hydroxybutyrylcarnitine (1)
1-linoleoyl-GPA (18:2)* (1)
1-methyl-4-imidazoleacetate (1)
1-methylhistidine (1)
1-methylnicotinamide (1)
12,13-DiHOME (1)
16a-hydroxy DHEA 3-sulfate (1)
2'-O-methylcytidine (1)
2'-O-methyluridine (1)
2'-deoxyuridine (1)
2,3-dihydroxyisovalerate (1)
2,6-dihydroxybenzoic acid (1)
2-aminoadipate (1)
2-aminobutyrate (1)
2-aminoheptanoate (1)
2-aminooctanoate (1)
2-aminophenol sulfate (1)
2-hydroxy-3-methylvalerate (1)
2-hydroxyacetaminophen sulfate* (1)
2-hydroxyadipate (1)
2-hydroxybutyrate/2-hydroxyisobutyrate (1)
2-hydroxydecanoate (1)
2-hydroxyglutarate (1)
2-hydroxyibuprofen (1)
2-hydroxynervonate* (1)
2-hydroxyoctanoate (1)
2-hydroxypalmitate (1)
2-hydroxyphenylacetate (1)
2-hydroxystearate (1)
2-isopropylmalate (1)

Study type

Transcription profiling by array (4)
ChIP-chip by array (2)
Methylation profiling by array (2)
Comparative genomic hybridization by array (1)
Methylation profiling by high throughput sequencing (1)

Release Date

2021 (60)
2024 (56)
2018 (51)
2025 (49)
2022 (48)
2023 (45)
2020 (31)
2017 (26)
2019 (25)
2015 (20)
2016 (19)
2013 (15)
2011 (12)
2026 (12)
2012 (10)
2014 (8)
2010 (6)
2009 (4)
2004 (1)
1999 (1)

Lab affiliation

Academy of Orthopedics, Guangdong Province, Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, China (1)
Calico Life Sciences (1)
Centre for Proteome Research, Institute of Systems, Molecular and Integrative Biology, University of Liverpool; Liverpool, UK (1)
Department of Biochemistry & Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton 3800, Australia (1)
Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, North Ryde, NSW 2109 (1)
Department of Cellular and Molecular Pharmacology University of California San Francisco (UCSF) San Francisco, CA 94158 USA (1)
Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China (1)
Faculty of Chinese Materia Medica; Cultivation and identification of Chinese herbal medicine/Plant Pathology; Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan, P.R. China (1)
Hayley Sharpe, Signalling, Babraham Institute, Cambridge, UK (1)
National Taiwan University Hispital (1)
Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, 08901, USA Graduate Program in Cellular and Molecular Pharmacology, Graduate School of Biomedical Sciences, Rutgers (1)
Structural Biology (1)
Zhejiang University School of Medicine (1)

Previous page
1 / 53
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 53
Next page

Sort by:

Relevance

Page size

Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study.

Not available

S-EPMC5131925 | biostudies-literature

Therapeutic mechanisms of the medicine and food homology formula Xiao-Ke-Yin on glucolipid metabolic dysfunction revealed by transcriptomics, metabolomics and microbiomics in mice.

Not available

S-EPMC10193706 | biostudies-literature

Vegetable Signatures Derived from Human Urinary Metabolomic Data in Controlled Feeding Studies

Examination of changes in urinary metabolomic profiles after vegetable ingestion may lead to new methods of assessing plant food intake. To this regard, we developed a proof-of-principle methodology to identify urinary metabolomic signatures for spinach, celery, and onion. Three feeding studies were...

2019-05-30 | MTBLS683 | MetaboLights

Microstructure (EBSD-KAM)-Informed Selection of Single-Powder Soft Magnetics for Molded Inductors.

Not available

S-EPMC12608291 | biostudies-literature

1,2;5,6-Di-O-isopropyl-idene-3-C-nitro-methyl-α-d-allofuran-ose.

Not available

S-EPMC3120445 | biostudies-literature

Targeting ERAP enhances anti-tumor immunity by disrupting the NKG2A/HLA-E inhibitory checkpoint

Tsao H, Anderson S, Finn KJ, Perera J, Pass LF, Schneider EM, Jiang A, Fetterman R, Chuong CL, Kozuma K, Stickler MM, Creixell M, Klaeger S, Phulphagar KM, Rachimi S, Verzani EK, Olsson N, Dubrot J, Pech MF, Silkworth W, Lane-Reticker SK, Allen PM, Ibrahim K, Knudsen NH, Cheng AY, Long AH, Ebrahimi-...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606) Mus Musculus (ncbitaxon:10090)

2024-05-10 | MSV000094736 | MassIVE

Successful Antiviral Therapy Reduces Risk of Schizophrenia Among Chronic Hepatitis C Patients: A Nationwide Real-World Taiwanese Cohort (T-COACH).

Not available

S-EPMC7751132 | biostudies-literature

Cold plasma-induced ovalbumin amyloid fibrils: Morphological characteristics and stability on astaxanthin-loaded high internal phase emulsions.

Not available

S-EPMC12357059 | biostudies-literature

Engineering Escherichia coli via introduction of the isopentenol utilization pathway to effectively produce geranyllinalool.

Not available

S-EPMC11515624 | biostudies-literature

Human placental mesenchymal stem cells ameliorate liver fibrosis in mice by upregulation of Caveolin1 in hepatic stellate cells.